Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation

Pulmonary hypertension (PH) in heart transplant (HT) candidates is associated with increased post-transplant mortality, and may represent a contraindication to HT. Vasorectivity studies test PH reversibility, but how their results match post-HT outcome is unexplored. In addition, data guiding organ allocation in recipients with PH are lacking.